Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease

Dopamine agonists such as pramipexole (PPX) have first been proposed as adjunctive treatment to levodopa (L-DOPA) for patients with Parkinson's disease (PD) and then as a monotherapy alternative to alleviate dyskinesia. Treatment with PPX has overall been associated with improvement in parkinso...

Descripción completa

Detalles Bibliográficos
Autores principales: Piedad, John C. P., Cavanna, Andrea E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306931/
https://www.ncbi.nlm.nih.gov/pubmed/22496989
http://dx.doi.org/10.1155/2012/473769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306931/
https://www.ncbi.nlm.nih.gov/pubmed/22496989
http://dx.doi.org/10.1155/2012/473769

Ejemplares similares